S
Shou-Jiang Gao
Researcher at University of Pittsburgh
Publications - 218
Citations - 12218
Shou-Jiang Gao is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Kaposi's sarcoma-associated herpesvirus & Lytic cycle. The author has an hindex of 52, co-authored 202 publications receiving 10964 citations. Previous affiliations of Shou-Jiang Gao include University of Texas Health Science Center at San Antonio & Chinese Academy of Sciences.
Papers
More filters
Journal ArticleDOI
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.
Shou-Jiang Gao,Lawrence A. Kingsley,Ming Li,Wei Zheng,Carlo Parravicini,J Ziegler,Robert U. Newton,Charles R. Rinaldo,Alfred J. Saah,John P. Phair,Roger Detels,Yuan Chang,Patrick S. Moore +12 more
TL;DR: Antibody kinetics showed that more than half of the AIDS–KS patients who were examined IgG–seroconverted before KS development, and antibody levels did not decline after seroconversion, suggest that the rate of infection was constant and that the risk of developing KS once infected with KSHV is not highly dependent on the duration of infection.
Journal ArticleDOI
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
Guy Simpson,Thomas F. Schulz,Denise Whitby,Pamela M. Cook,Chris Boshoff,Lucille Rainbow,Mark R Howard,Shou-Jiang Gao,Roy A. Bohenzky,Peter Simmonds,C. A. Lee,A de Ruiter,Angelos Hatzakis,Richard S. Tedder,Ian Weller,R A Weiss,Patrick S. Moore +16 more
TL;DR: The distribution of antibodies to both a capsid-related recombinant protein and latent antigen of KSHV strongly supports the view that infection with this virus is largely confined to individuals with, or at increased risk for, KS.
Journal ArticleDOI
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.
Patrick S. Moore,Shou-Jiang Gao,Geraldina Dominguez,Ethel Cesarman,Octavian Lungu,Daniel M. Knowles,Richard Garber,Philip E. Pellett,Duncan J. McGeoch,Yuan Chang +9 more
TL;DR: The agent is defined as a new human herpesvirus provisionally assigned the descriptive name KS-associated herpesv virus; its formal designation is likely to be human herpes virus 8.0, the first member of this genus known to infect humans.
Journal ArticleDOI
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
Shou-Jiang Gao,Lawrence A. Kingsley,Donald R. Hoover,Thomas J. Spira,Charles R. Rinaldo,Alfred J. Saah,John P. Phair,Roger Detels,Preston Parry,Yuan Chang,Patrick S. Moore +10 more
TL;DR: In most patients with kaposi's sarcoma and AIDS, seroconversion to positivity for antibodies against KSHV-related nuclear antigens occurs before the clinical appearance of Kaposi's Sarcoma.
Journal ArticleDOI
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.
Lucille Rainbow,Georgina M. Platt,Guy Simpson,R Sarid,Shou-Jiang Gao,H Stoiber,C S Herrington,Patrick S. Moore,Thomas F. Schulz +8 more
TL;DR: It is demonstrated that orf73 encodes the 222- to 234-kDa LNA, is a component of LANA, and is expressed in KS tumor cells, as well as the characteristic speckled nuclear immunofluorescence pattern ofLANA on Western blots.